natgillin/translations-raw huggingface dataset:
The method according to claim 1, wherein the temperature of the solution is maintained at a temperature which is at least about 0,5°C higher than the freezing point of the solution. 
Postupak prema patentnom zahtjevu 1, naznačen time, da se temperatura otopine održava na temperaturi koja je najmanje oko 0,5°C viša od točke ledišta otopine.
The method according to claim 1, wherein the temperature of the solution is maintained at a temperature which is at least about 1,0°C higher than the freezing point of the solution, and preferably at least about 1,5°C higher. 
Postupak prema patentnom zahtjevu 1, naznačen time, da se temperatura otopine održava na temperaturi koja je najmanje oko 1,0°C viša od točke ledišta otopine, i poželjno je najmanje oko 1,5°C viša.
The method according to claim 1, wherein the fish is pre-cooled to a temperature of below about 6°C and preferably below about 4°C, gutted and/or bled before step b). 
Postupak prema patentnom zahtjevu 1, naznačen time, da se riba pothlađuje do temperature ispod oko 6°C, i poželjno ispod oko 4°C, očišćena od iznutrica i/ili krvi prije koraka b).
The method according to claim 1, wherein the at least one first container (6) is an elongated cylindrical or semi-cylindrical tank and comprises a spiral shaped blade (4) mounted on a rotation axis to convey the objects along the length of the tank. 
Postupak prema patentnom zahtjevu 1, naznačen time, da se kod najmanje jednog prvog kontejnera (6) radi o izduženom cilindričnom ili polucilindričnom rezervoaru i koji obuhvaća spiralno formiranu oštricu (4) montiranu na rotacijskoj osi u svrhu transporta predmeta uzduž duljine rezervoara.
A method of synthesis according to claim 1, wherein said oxidation in said thiosulfonic acid formation (TSAF) step is by reaction with an oxidizing agent that is or comprises Cr(VI), preferably an oxidizing agent that is or comprises Na2Cr2O7. 
Postupak sinteze prema zahtjevu 1, naznačen time, da se navedena oksidacija u koraku tvorbe tiosulfonske kiseline (TSAF) izvodi putem reakcije s oksidacijskim sredstvom koje jest ili obuhvaća Cr(VI), poželjno s oksidacijskim sredstvom koje jest ili obuhvaća Na2Cr2O7.
A method of synthesis according to any one of the preceding claims, wherein said reducing agent that is or comprises Fe(0), is a reducing agent that is or comprises metallic iron, wherein said metallic iron is preferably used in excess, and wherein the excess metallic iron is not removed from the reaction mixture after reaction completion, and/or wherein said reduction in said nitrosyl reduction (NR) step is preferably performed under acidic conditions. 
Postupak sinteze prema bilo kojem od prethodnih zahtjeva, naznačen time, da je navedeno redukcijsko sredstvo koje jest ili obuhvaća Fe(0), takvo redukcijsko sredstvo koje jest ili obuhvaća kovinsko željezo, pri čemu se kovinsko željezo upotrebljava u suvišku, te time, da se višak kovinskog željeza ne odstranjuje iz reakcijske smjese nakon završetka reakcije, i/ili time, da se navedena redukcija u spomenutom koraku nitrozilne redukcije (NR) poželjno izvodi pod kiselinskim uvjetima.
A method of synthesis according to claim 8, wherein the chloride is hydrochloric acid, and wherein chloride salt formation (CSF) is preferably performed at a relatively low pH of 0 to 2, more preferably about 1. 
Postupak sinteze prema zahtjevu 8, naznačen time, da klorid je klorovodična kiselina, i pritom se tvorba kloridne soli (CSF) poželjno izvodi uz relativno nisku pH-vrijednost od 0 do 2, još poželjnije uz oko 1.
A method according to any preceding claim, wherein a filtration agent is added to the reaction vessel in which the nitrosyl reduction (NR), thiosulfonic acid formation (TSAF), and oxidative coupling (OC) steps are completed, wherein the filtration agent is preferably a filtration agent which is or comprises cellulose. 
Postupak prema bilo kojem od prethodnih zahtjeva, naznačen time, da se dodaje filtracijsko sredstvo u reakcijsku posudu u kojoj se završavaju koraci nitrozilne redukcije (NR), tvorbe tiosulfonske kiseline (TSAF), i oksidacijskog spajanja (OC), pri čemu je filtracijsko sredstvo poželjno takvo filtracijsko sredstvo koje jest ili obuhvaća celulozu.
at least one second converter unit (540b; 640b; 740c,d; 840c,d; 940c) connected to the secondary side of the second transformer arrangement, wherein the first and second converter units are interconnected by means of a DC connection (560, 562; 660, 662; 760, 762, 764; 860, 862; 960, 962), characterized in that at least parts of both the first and the second transformer arrangement are integrated in one physical transformer unit (530a-c; 630a-f; 730a-f; 830a-f; 930a-f), within a common transformer casing, wherein two separate transformer cores are provided within the transformer casing. 
najmanje jednu drugu pretvaračku jedinicu (540b; 640b; 740c,d; 840c,d; 940c) spojenu na sekundarnu stranu sklopa drugog transformatora, pri čemu su prva i druga pretvaračka jedinica međusobno spojene pomoću DC spoja (560, 562; 660, 662; 760, 762, 764; 860, 862; 960, 962), naznačen time što su barem dijelovi i prvog i drugog sklopa transformatora integrirani u jednu fizičku transformatorsku jedinicu (530a-c; 630a-f; 730a-f; 830a-f; 930a-f), unutar zajedničkog kućišta transformatora, pri čemu su unutar kućišta transformatora predviđene dvije odvojene jezgre transformatora.
The AC-AC HVDC converter system according to claim 4, wherein the transformer is a two-phase three-winding transformer (530a-c). 
Sustav pretvarača AC-AC HVDC prema zahtjevu 4, naznačen time što je transformator dvofazni transformator s tri namotaja (530a-c).
The AC-AC HVDC converter system according to claim 4, wherein the transformer is a two-phase two-winding transformer (630a-f; 730a-f; 830a-f; 930a-f). 
Sustav pretvarača AC-AC HVDC prema zahtjevu 4, naznačen time što je transformator dvofazni transformator s dva namotaja (630a-f; 730a-f; 830a-f; 930a-f).
The AC-AC HVDC converter system according to claim 1, wherein part of two first transformer arrangements of the at least one first transformer arrangement are integrated in one physical transformer unit (730a-f; 830a-f; 930a-f). 
Sustav pretvarača AC-AC HVDC prema zahtjevu 1, naznačen time što je dio dva prva sklopa transformatora od barem jednog prvog sklopa transformatora integriran u jednu fizičku transformatorsku jedinicu (730a-f; 830a-f; 930a-f).
A formulation of an isolated compound of formula I: where: is hydroxy or β-D-xylopyranoside, 
Formulacija izoliranog spoja formule I:, gdje: je hidroksi ili β-d-ksilopiranozid,
and R2 forms, together with carbon 9, a fused cyclopropyl ring, and ---- represents a single bond between carbons 9 and 11 in an effective amount for use in treating Alzheimer's disease, Parkinson's disease, Huntington's disease, macular degeneration, anemia or a chronic or acute condition of the epidermis selected from the group consisting of a wound, a burn, an abrasion, an incision, a graft site, a lesion caused by an infectious agent, a chronic venous ulcer, a diabetic ulcer, a compression ulcer, a pressure sore, a mucosal sore or ulcer and keloid formation, by increasing telomerase activity in cells or tissue of the patient. 
tvori, zajedno s ugljikom 9, kondenzirani ciklopropilni prsten, a ---- predstavlja jednostruku vezu između ugljika 9 i 11, naznačena time što je spoj u količini djelotvornoj u upotrebi u liječenju Alzheimerove bolesti, Parkinsonove bolesti, Huntingtonove bolesti, makularne degeneracije, anemije ili kroničnog ili akutnog stanja epidermisa kojeg se bira iz skupine koju čine rana, opeklina, abrazija, incizija, mjesto presatka, lezija uzrokovana uzročnikom zaraze, kronični venski ulkus, dijabetični ulkus, kompresijski ulkus, dekubitus, mucosal sore ili ulkusna i keloidna formacija, povećavanjem aktivnosti telomeraze u pacijentovim stanicama ili tkivu.
A method for cleaning an auditory canal of a subject, comprising applying to the auditory canal a composition comprising a) 5% to 40%, by weight of the total weight of the composition, of an ester of vitamin E with a carboxylic acid of formula R—COOH, in which R is an alkyl radical having 1 to 19 carbon atoms, or an alkenyl or alkynyl radical having 2 to 19 carbon atoms, and b) an oily vehicle selected from the group consisting of hydrogenated polyisobutene, hydrogenated polydecene, mixtures of hydrogenated polyisobutene and hydrogenated polydecene with hydrogenated polyolefins, Caprylic/Capric Triglyceride, Cyclopentasiloxane, and mixtures thereof. 
Neterapijska upotreba pripravka za topikalnu primjenu u slušnom kanalu za čišćenje slušnog kanala, naznačena time, što navedena kompozicija sadrži 5% do 40%, po težini od ukupne težine pripravka, estera vitamina E s karboksilnom kiselinom formule R-COOH, u kojoj je R alkil radikal koji ima 1 do 19 atoma ugljika, ili alkenil ili alkinil radikal koji ima 2 do 19 atoma ugljika, i uljni nosač odabran iz grupe koja se sastoji od hidrogeniranih poliizobutena, hidrogeniranih polidecena i smjesa hidrogeniranog poliizobutena i/ili hidrogeniranog polidecena s hidrogeniranim poliolefinima, posebno hidrogeniranim C6-C14 hidrogeniranim poliolefinima, kaprilnog/kaprinskog triglicerida, ciklopentasiloksana, i njihovih smjesa.
A method of controlling undesirable vegetation which comprises applying to an area where control is desired a herbicidally effective amount of the composition of any one of claims 1-6. 
Postupak kontroliranja neželjenog raslinja, naznačen time što se sastoji u primjeni na području gdje je poželjna kontrola herbicidno djelotvorne količine pripravka u skladu s bilo kojim od patentnih zahtjeva 1-6.
A method of controlling undesirable vegetation comprising applying to an area where control is desired (a) 1.25 to 10 g ae/ha of a compound of formula (I) or an agriculturally acceptable salt or a C1-4 alkyl or benzyl ester thereof and (b) 30 to 240 g ai/ha of flufenacet in form of a synergistic combination, with the proviso that no glufosinate, L-glufosinate, bialaphos, or diflufenican is also applied. 
Postupak kontroliranja neželjenog raslinja, naznačen time što se sastoji u primjeni na području gdje je poželjna kontrola (a) 1,25 do 10 g ae/ha spoja formule (I), ili njegove agrikulturno prihvatljive sol ili C1-4 alkilnog ili benzilnog estera, i (b) 30 do 240 g ai/ha flufenaceta u obliku sinergističke kombinacije, uz uvjet da se uz to također ne primjenjuje glufosinat, L-glufosinat, bialafos, ili diflufenikan.
The method of claims 8 or 9 wherein the undesirable vegetation is controlled in rice, wheat, barley, triticale, oats, rye, corn, maize, cereals, pastures, grasslands, rangelands, fallowland, industrial vegetation management or rights-of-way. 
Postupak u skladu s patentnih zahtjeva 8 ili 9, naznačen time što se neželjeno raslinje kontrolira kod riže, pšenice, ječma, tritikale, zobi, raži, kukuruza, žitarica, pašnjaka, travnjaka, prerija, zemlje na ugaru, upravljanja industrijskim raslinjem ili lokalnih puteva.
The method of claims 8 or 9, wherein the undesirable vegetation is immature. 
Postupak u skladu s patentnih zahtjeva 8 ili 9, naznačen time što je neželjeno raslinje nezrelo.
The method of any one of claims 8-12, wherein the undesirable vegetation is controlled in glyphosate-, glufosinate-, dicamba-, phenoxy auxins-, pyridyloxy auxins-, aryloxyphenoxypropionates-, acetyl CoA carboxylase (ACCase) inhibitors-, imidazolinones-, acetolactate synthase (ALS) inhibitors-, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) inhibitors-, protoporphyrinogen oxidase (PPO) inhibitors-, triazines-, or bromoxynil-tolerant crop. 
Postupak u skladu s bilo kojim od patentnih zahtjeva 8-12, naznačen time što se neželjeno raslinje kontrolira kod usjeva koji podnose glifosat, glufosinat, dikambu, fenoksiauksine, piridiloksiauksine, ariloksifenoksipropionate, inhibitore acetil-CoA-karboksilaze (ACCaza), imidazolinone, inhibitore acetolaktat-sintaze (ALS), inhibitore 4-hidroksifenilpiruvat-dioksigenaze (HPPD), inhibitore protoporfirinogen-oksidaze (PPO), triazine ili bromoksinil.
A method of producing a compound of formula [1b] comprising a step of reacting a thiazole derivative of formula [4] and a benzene derivative of formula [3] under a presence of an acid or Lewis acid and a solvent: wherein, R1, R2, R3, R4, R5, R6, R13, R14, R15, R16, R17, E, G2, X1, X2, X3, X4, T and n are as defined in Claim 1. 
Postupak za proizvodnju spoja formule [1b] naznačen time što obuhvaća korak reakcije tiazolnog derivata formule [4] i benzenskog derivata formule [3] u prisutnosti kiseline ili Lewisove kiseline i otapala: pri čemu, R1, R2, R3, R4, R5, R6, R13, R14, R15, R16, R17, E, G2, X1, X2, X3, X4, T i n su kako je definirano u zahtjevu 1.
The device according to claim 1 wherein Localized Virtual Resource Blocks (LVRBs), which are mapped to PRBs, are allocated to the terminal by units of RBGs. 
Integrirani krug sukladno jednom od zahtjeva 1 do 9, naznačen time da su u drugoj dodjeli, lokalizirani virtualni blokovi resursa, LVRB-ovi, mapirani na PRB-ove, i LVRB-ovi su dodijeljeni uređaju mobilnoj stanici u jedinicama RBG-a.
each R5 is, independently, hydrogen, C1-4alkyl, imidazole, triazole, thiazole, pyridine, pyrimidine, oxetane, tetrahydrofuran, or tetrahydropyran, and each R5 group is optionally substituted with chloro, up to three fluorine atoms, up to two C1-2alkyl, CH2OH, CN, up to two OH, up to two OC1-2alkyl, a spirooxetane, pyrrolidine, or triazole, or two R5 groups together with the intervening nitrogen atom form a morpholine ring, azetidine ring, pyrrolidine ring, piperidine ring, or piperazine ring. 
i svaki R5 je, nezavisno, vodik, C1-4alkil, imidazol, triazol, tiazol, piridin, pirimidin, oksetan, tetrahidrofuran ili tetrahidropiran, i svaka R5 grupa je izborno supstituirana s klorom, do tri atoma fluora, do dva C1-2alkila, CH2OH, CN, do dva OH, do dva OC1-2alkila, spirooksetana, pirolidina ili triazola, ili dvije R5 grupe zajedno s atomom dušika koji je između formiraju morfolin prsten, azetidin prsten, pirolidin prsten, piperidin prsten ili piperazin prsten.
Direct solar radiation collecting and concentrating element, according to any one of claims 2 to 7, characterized in that a hollow compartment (5B) comprises at least one hole (5H) for the introduction of fluid. 
Element za prikupljanje i koncentriranje izravnog sunčevog zračenja, u skladu s patentnim zahtjevom 2, naznačen time što šuplji, hermetični i vodonepropusni odjeljci (5B) sadrže najmanje jednu rupu (5H), za ulaženje fluida.
Direct solar radiation collecting and concentrating element, according to any one of the preceding claims, characterized in that the container comprises at least one support arm (7H) attached to an external supporting structure. 
Element za prikupljanje i koncentriranje izravnog sunčevog zračenja, u skladu s patentnim zahtjevom 3, naznačen time što spremnik (5) sadrži najmanje jedan nosivi krak (7H), spojen s vanjskom nosivom strukturom.
Direct solar radiation collecting and concentrating element, according to claim 18, characterized in that a toothed piston (7I, 8C, 9C) is attached onto the support arm (7H) upon which the variations in pressure of the fluid in a hollow compartment (5B) is transmitted, said pressure variations setting the container into motion. 
Element za prikupljanje i koncentriranje izravnog sunčevog zračenja, u skladu s patentnim zahtjevom 4, naznačen time što je nazubljeni klip (71, 8C, 9C) pričvršćen na nosivi krak (7H), na kojeg se prenose varijacije u tlaku fluida u šupljim, hermetičnim i vodonepropusnim odjeljcima (5B), gdje varijacije tlaka uzrokuju kretanje spremnika (5).
Direct solar radiation collecting and concentrating element, according to claim 20, characterized in that the movement of the toothed piston (7I, 8C, 9C) is longitudinal and acts upon a fixed cogwheel (7F, 8D) which, in turn, acts upon an axis of the container, causing the container to rotate. 
Element za prikupljanje i koncentriranje izravnog sunčevog zračenja, u skladu s patentnim zahtjevom 5, naznačen time što je kretanje nazubljenog klipa (71, 8C, 9C) uzdužno i djeluje na fiksirani zupčanik (7F, 8D) koji, pak, djeluje na os spremnika (5), uzrokujući vrtnju spremnika (5).
Direct solar radiation collecting and concentrating element, according to any one of the preceding claims, characterized in that the sides of the container include at least one tube (9H) connected to a pressure valve (9E) allowing the exchange of fluid pressure between the opposite sides of the container. 
Element za prikupljanje i koncentriranje izravnog sunčevog zračenja, u skladu s patentnim zahtjevom 6, naznačen time što spremnik (5) sadrži najmanje jednu cijev (9H), spojenu s tlačnim ventilom (9E), koji omogućuje razmjenu tlaka fluida između suprotnih strana spremnika (5).
Direct solar radiation collecting and concentrating element according to any one of the preceding claims, characterized in that the container is secured onto an external structure via an arm (5E) with integrated pressure tubes, either via two arms on the north and south sides, respectively, attached onto the supporting line (2C), or via four arms attached onto the north and south sides, respectively, supported by two supporting lines (2C) of the aforesaid external structure. 
Element za prikupljanje i koncentriranje izravnog sunčevog zračenja u skladu s patentnim zahtjevom 8, naznačen time što je spremnik (5) učvršćen na vanjsku strukturu preko kraka (5E) s integriranim tlačnim cijevima, bilo preko dva kraka na sjevernoj odnosno južnoj strani, pričvršćena na nosivu liniju (2C), ili preko četiri kraka pričvršćena na sjevernoj odnosno južnoj strani, koje nose dvije nosive linije (2C) vanjske strukture.
A compound having the following structure: 
Spoj koji ima slijedeću strukturu:
The transfer vehicle of claim 2 or claim 3, wherein the nucleic acid is RNA. 
Nosač transfera prema zahtjevu 2 ili zahtjevu 3, naznačen time što je nukleinska kiselina RNK.
The transfer vehicle of any one of claims 2 to 6, wherein the transfer vehicle is a lipid nanoparticle or liposome. 
Nosač transfera prema bilo kom od zahtjeva 2 do 6, naznačen time što je nosač transfera lipidna nanočestica ili liposom.
The transfer vehicle of any one of claims 2 to 7, wherein the transfer vehicle encapsulates the nucleic acid or protein. 
Nosač transfera prema bilo kojem od zahtjeva 2 do 7, naznačen time što nosač transfera inkapsulira nukleinsku kiselinu ili protein.
The transfer vehicle of any one of claims 2 to 8, wherein the transfer vehicle further comprises one or more therapeutic or diagnostic agents. 
Nosač transfera prema bilo kom od zahtjeva 2 do 8, naznačen time što nosač transfera nadalje sadrži jedno ili više terapeutskih ili dijagnostičkih sredstava.
The transfer vehicle or pharmaceutical composition of any one of claims 2 to 10, for use in a method of treating a disease in a subject which results from a protein deficiency, wherein the nucleic acid encodes the protein that the subject is deficient in, or the protein is the protein that the subject is deficient in. 
Nosač transfera ili farmaceutski pripravak prema bilo kojem od zahtjeva 2 do 10, naznačen time što je za upotrebu za liječenje bolesti koje su rezultat nedostatka proteina kod subjekta, pri čemu nukleinska kiselina kodira protein koji nedostaje subjektu, ili protein je protein koji nedostaje subjektu.
A process for preparing the compound of claim 1, the process comprising step (a), of forming compound 3 from compounds 1 and 2: 
Postupak dobivanja spoja prema zahtjevu 1, naznačen time što postupak sadrži korak (a), tvorbe spoja 3 iz spoja 1 i 2:
The process of claim 14 or claim 15, wherein the strong acid used in step (b) is trifluoroacetic acid (TFA). 
Postupak prema zahtjevu 14 ili zahtjevu 15, naznačen time što je jaka kiselina koja se koristi u koraku (b) trifluorooctena kiselina (TFA).
A system (1) for stowing, preserving and distributing fodder in ships for transporting large quantities of animals, characterized in that it comprises: 
Sustav (1) za utovar, konzerviranje i raspodjelu krmiva u brodovima za prijevoz velikih količina životinja, naznačen time što sadrži:
at least one silo (2, 3) for storing the fodder, located in a region of the ship (N) that is located below deck; 
najmanje jedan silos (2, 3) za spremanje krmiva, smješten u području broda (N) smještenom ispod palube;
automated distribution means (7) for the distribution of the fodder from said intermediate region (5) to said compartments (6) for the animals to be fed, 
automatizirano sredstvo za raspodjelu (7) za raspodjela krmiva od navedenog međupodručja (5) do navedenih odjeljaka (6) za životinje koje treba nahraniti, naznačen time što dodatno sadrži
automated loading means (8) for the loading of the fodder into said at least one storage silo (2, 3); 
automatizirano sredstvo za utovar (8) za utovar krmiva u navedeni najmanje jedan spremišni silos (2, 3);
The system (1) according to one or more of the preceding claims, characterized in that the control and monitoring element (50) of the programmable electronic type, which is functionally connected to said shutters that can be driven, to said conveyors (9, 18, 19, 20, 21, 22, 29, 30, 31, 33, 34) and to said bucket elevators (27, 28) for their actuation according to preset programs. 
Sustav (1) u skladu s jednim ili više prethodnih patentnih zahtjeva, naznačen time što je element za upravljanje i praćenje (50) programirljivog elektronskog tipa funkcionalno spojen s navedenim zatvaračima koje se može pogoniti, s navedenim transporterima (9, 18, 19, 20, 21, 22, 29, 30, 31, 33, 34) i s navedenim vjedrenim dizalima (27, 28) radi njihovog aktuiranja prema unaprijed zadanim programima.
A method for manufacturing an antistatic anisotropic conductive film comprising a mixture of a nonconductive matrix and conductive particles, said conductive particles having an aspect ratio from 1 -100, characterised by 
Postupak proizvodnje antistatičkog anizotropno vodljivog filma koji sadrži smjesu od nevodljive matrice i vodljivih čestica, gdje navedene vodljive čestice imaju omjer dimenzija od 1 do 100, naznačen time što se sastoji u
providing a first surface; 
osiguravanju prve površine;
applying a layer of the mixture over the first surface, the mixture having a first viscosity which allows the conductive particles to rearrange within the layer; 
primjeni sloja smjese po prvoj površini, gdje smjesa ima prvu viskoznost, koja omogućuje premještanje vodljivih čestica u sloju;
changing the viscosity of the layer to a second viscosity, said second viscosity being higher than the first viscosity in order to mechanically stabilise the layer and preserve the conductive pathways. 
mijenjanje viskoznosti sloja u drugu viskoznost, gdje je navedena druga viskoznost veća od prve viskoznosti kako bi se mehanički stabiliziralo sloj i očuvalo vodljive puteve.
A method in accordance with claim 1 or 2, characterised by that at least one of the alignment electrodes is in direct contact with the layer. 
Postupak u skladu s patentnim zahtjevom 1 ili 2, naznačen time što je najmanje jedna od poravnavajućih elektroda u izravnom kontaktu sa slojem.
A method in accordance with claim 1 and any of the previous claims, characterised by that the matrix is totally or partly removed from the layer after step d. 
Postupak u skladu s patentnim zahtjevom 1 i bilo kojim od prethodnih patentnih zahtjeva, naznačen time što se matricu posve ili djelomično uklanja iz sloja nakon koraka d.
sodium carbonate, potassium carbonate, or cesium fluoride; or 
natrijev karbonat, kalijev karbonat, ili cezijev fluorid; ili
The process according to claim 1, wherein hydrochloric acid is present in an amount of 5 to 8 equivalents based on the compound of Formula IIa. 
Postupak prema zahtjevu 1, naznačen time što se klorovodična kiselina nalazi u količini oko 5 do 8 ekvivalenata na osnovu spoja Formule IIa.
The process according to claim 1 to 8, wherein said reacting of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile dihydrochloride salt with a compound of Formula VI is carried out in the presence of at least two equivalents of a second base. 
Postupak prema zahtjevu 1 do 8, naznačen time što se navedena reakcija 2-(3-(4-(7H-pirolo[2,3-d]pirimidin-4-il)-1H-pirazol-1-il)azetidin-3-il)acetonitril dihidrokloridne soli sa spojem Formule VI provodi u prisutnosti najmanje dva ekvivalenata druge baze.